OverviewChartNewsTraderScreen

UC TUR.WAR.OP.END. BRM/  DE000HD2GFW3  /

gettex
2024-06-14  9:41:39 PM Chg.0.0000 Bid9:59:00 PM Ask9:59:00 PM Underlying Strike price Expiration date Option type
0.3500EUR 0.00% 0.3200
Bid Size: 100,000		 0.3300
Ask Size: 100,000		 BRISTOL-MYERS SQUIBB... 37.9094 - 2078-12-31 Call
GlobeNewswire 06-14 Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored...
GlobeNewswire 06-12 Crossject appoints Dan Chiche, MD as Chief Medical Officer North America
GlobeNewswire 06-11 Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
GlobeNewswire 06-11 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire 06-11 Allyx Therapeutics Announces First Alzheimer’s Disease Patient Treated with Lead Compound ALX-001
GlobeNewswire 06-10 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 06-10 C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors
GlobeNewswire 05-31 Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting P...
GlobeNewswire 05-30 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire 05-24 Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
GlobeNewswire 05-23 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire 05-23 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
GlobeNewswire 05-22 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 05-22 Anavex Life Sciences Announces Expansion of Leadership Team
GlobeNewswire 05-16 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 05-15 Lantheus Announces Executive Appointments to Accelerate Innovation
GlobeNewswire 05-14 Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Healthcare-Industry Executive, Dav...
GlobeNewswire 05-14 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire 05-13 Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 05-08 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-08 Immunocore reports first quarter financial results and provides a business update
GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 05-02 Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., ...
GlobeNewswire 05-01 Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
GlobeNewswire 05-01 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...